PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the top robotics to buy according to analysts.
Procept Biorobotics Corp (PRCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 190,292 | $10,960,819 | -65% | 0.01% |
| 2. | Rhenman & Partners Asset Management Henrik Rhenman | 190,000 | $10,944,000 | -58% | 1.38% |
| 3. | Osterweis Capital Management John Osterweis | 168,615 | $9,712,224 | -3% | 0.46% |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 159,600 | $9,192,960 | -28% | 0.01% |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 100,000 | $5,760,000 | +100% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.26 | 20,000 | $785,138.00 | 863,159 | 2025-08-13 | Filing | |
| $24.43 | 940 | $22,960.63 | 147,713 | 2022-03-11 | Filing | |
| $25.00 | 3,200 | $80,000.00 | 3,200 | 2021-09-17 | Filing | |
| $25.00 | 440,000 | $11,000,000.00 | 11,222,662 | 2021-09-17 | Filing | |
| $25.00 | 10,000 | $250,000.00 | 45,074 | 2021-09-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $62.33 | 5,049 | $314,692.56 | 14,363 | 2025-06-12 | Filing | |
| $61.28 | 19,951 | $1,222,563.36 | 19,412 | 2025-06-12 | Filing | |
| $64.27 | 5,717 | $367,447.03 | 39,363 | 2025-06-11 | Filing | |
| $63.47 | 11,495 | $729,602.59 | 45,080 | 2025-06-11 | Filing | |
| $62.59 | 7,788 | $487,475.84 | 56,575 | 2025-06-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,799,653 | $449,260,003 | 0.03% | |
| 2. | 5,248,072 | $302,288,946 | 0% | |
| 3. | 4,208,229 | $242,393,961 | 0% | |
| 4. | 2,156,856 | $124,234,906 | 0.04% | |
| 5. | 1,598,349 | $92,064,902 | 0.39% |
News See All
Top 10 Robotics Stocks to Buy According to Analysts
Markets and Markets research projects that the industrial robotics market will develop at a compound annual growth rate (CAGR) of 14% from $17 billion in 2024 to $35 billion by 2030.
Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best medical device stocks to buy according to analysts. On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT...
12 Best Medical Device Stocks to Buy According to Analysts
On July 7, CNBC’s Chery Kang and Elaine Yu talked about China’s imposition of reciprocal tariffs on the import of medical devices from the European Union.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the PROCEPT BioRobotics Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
What Makes PROCEPT BioRobotics Corporation (PRCT) an Investment Bet?
Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript April 24, 2025PROCEPT BioRobotics Corporation beats earnings expectations.
10 Best Robotics Stocks to Buy According to Billionaires
The robotics industry has grown modestly over the past few years. Robotic companies are growing faster than ever, driven by advancements in technology since the emergence of AI.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to PROCEPT BioRobotics Fourth Quarter and Year End 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.
10 Best Mid-Cap Growth Stocks to Buy According to Analysts
Investing in mid-cap growth stocks has long been a favoured strategy for investors looking to strike a balance between the stability of large-cap companies and the high-growth potential of smaller firms...
Billionaire Hedge Funds
